Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants.

MLA

Niyomnaitham, Suvimol, et al. “Immunogenicity of a Fractional or Full Third Dose of AZD1222 Vaccine or BNT162b2 Messenger RNA Vaccine after Two Doses of CoronaVac Vaccines against the Delta and Omicron Variants.” International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, vol. 129, Apr. 2023, pp. 19–31. EBSCOhost, https://doi.org/10.1016/j.ijid.2023.01.022.

APA

Niyomnaitham, S., Jongkaewwattana, A., Meesing, A., Pinpathomrat, N., Nanthapisal, S., Hirankarn, N., Siwamogsatham, S., Kirdlarp, S., Chaiwarith, R., Lawpoolsri, S., Phanthanawiboon, S., Thitithanyanont, A., Hansasuta, P., Chaiyaroj, S., & Pitisuttithum, P. (2023). Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 129, 19–31. https://doi.org/10.1016/j.ijid.2023.01.022

Chicago

Niyomnaitham, Suvimol, Anan Jongkaewwattana, Atibordee Meesing, Nawamin Pinpathomrat, Sira Nanthapisal, Nattiya Hirankarn, Sarawut Siwamogsatham, et al. 2023. “Immunogenicity of a Fractional or Full Third Dose of AZD1222 Vaccine or BNT162b2 Messenger RNA Vaccine after Two Doses of CoronaVac Vaccines against the Delta and Omicron Variants.” International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases 129 (April): 19–31. doi:10.1016/j.ijid.2023.01.022.